Active Targeting

Active Targeting is a targeted drug delivery strategy in which therapeutic agents, usually loaded into carrier systems such as nanoparticles, are directed to specific cells, tissues, or subcellular compartments through the deliberate incorporation of ligands (e.g., antibodies, peptides, aptamers, or small molecules) that bind selectively to overexpressed receptors or other molecular markers at the target site.

167

Publications

11.6K

Citations

1.1K

Authors

385

Institutions

Publications per year

2017–2026

80

Authors

1.1K

  1. AO
    Aleksandra Olow

    University of California, San Francisco, United States

    3 publications · 168 citations

    3

    h-index

  2. DR
    David R. Reichman

    Columbia University, United States

    3 publications · 168 citations

    3

    h-index

  3. JL
    John L. Weber

    Columbia University, United States

    3 publications · 168 citations

    3

    h-index

  4. OF
    Olugbeminiyi Fadeyi

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    3 publications · 168 citations

    3

    h-index

  5. NE
    Nicholas E. S. Tay

    Columbia University, United States

    3 publications · 168 citations

    3

    h-index

1–5 of 1.1K

Venues

  1. Journal of Controlled Release

    7 publications · 355 citations

    7

    h-index

  2. Small

    5 publications · 275 citations

    6

    h-index

  3. International Journal of Pharmaceutics

    5 publications · 184 citations

    5

    h-index

  4. ACS Nano

    5 publications · 1.7K citations

    5

    h-index

  5. Advanced Drug Delivery Reviews

    4 publications · 410 citations

    4

    h-index

1–5